During the past decade, Vince and Associates Clinical Research, Inc. conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vince and Associates Clinical Research, Inc." #1 sponsor was "Cephalon" with 4 trials, followed by "Shire" with 4 trials sponsored, "Pfizer" with 2 trials sponsored, "22nd Century Group, Inc." with 1 trials sponsored and "Avanir Pharmaceuticals" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vince and Associates Clinical Research, Inc." #1 collaborator was "Vince & Associates Clinical Research, Inc." with 2 trials as a collaborator, "Algorithme Pharma Inc" with 1 trials as a collaborator and "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Vince and Associates Clinical Research, Inc." are "ADHD" (4 trials), "Healthy" (4 trials), "Chronic Shift Work Sleep Disorder" (2 trials), "ADHD Specifically With Executive Function Impairment" (1 trials) and "Anxiety Disorders" (1 trials). Many other conditions were trialed in "Vince and Associates Clinical Research, Inc." in a lesser frequency.

Most popular intervention types in "Vince and Associates Clinical Research, Inc." are "Drug" (20 trials), "Other" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "SPD489" (2 trials), "AVP-786" (1 trials), "AVP-923" (1 trials) and "Armodafinil 100 to 250 mg/day" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vince and Associates Clinical Research, Inc." are 21 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Vince and Associates Clinical Research, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Vince and Associates Clinical Research, Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Vince and Associates Clinical Research, Inc., 11 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

Vince and Associates Clinical Research, Inc. has several departments that took part in Clinical trials: "Algorithme Pharma." - 17 trials